朝威控股(08059.HK)前三季度虧損收窄85.8%至1825.5萬港元
格隆匯11月11日丨朝威控股(08059.HK)發佈三季度業績,截至2019年9月30日止九個月,公司實現收益7020萬港元,同比下降39.0%;毛利2350.7萬港元,同比增長18.3%;公司擁有人應占期內虧損1825.5萬港元,同比收窄85.8%;基本每股虧損1.81港仙;不派息。
公告表示,報告期內虧損收窄主要由於行政及其他營運開支比2018年期間減少7680萬港元;按公平值計入損益金融資產淨虧損3570萬港元於2018年期間確認;毛利比2018年期間上升360萬港元;及融資成本比2018年期間增加150萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.